Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reetesh K Pai

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant ImatinibJoshua B Brown, Reetesh K Pai, Melissa A Burgess, et al.
The American Journal of Surgical Pathology|July 21, 2016
MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional AdenomasLama Farchoukh, Shih-Fan Kuan, Beth Dudley, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 4, 2016
Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 DeficiencyMichelle Xia, Aatur D Singhi, Beth Dudley, et al.
The American Journal of Surgical Pathology|July 19, 2019
Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and AdenocarcinomaChangqing Ma, Patrick Henn, Caitlyn Miller, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2005
B-cell clonality determination using an immunoglobulin kappa light chain polymerase chain reaction methodReetesh K Pai, Artemis E Chakerian, John M Binder, et al.
Human Pathology|July 4, 2012
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtypingMichael A DiMaio, Shirley Kwok, Kelli D Montgomery, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 5, 2017
A Polyclonal Antibody to NKX3.1 Identifies Fungal Organisms From the EsophagusMartina Pejchal, Reetesh K Pai, Nadia F Habib-Bein, et al.
The American Journal of Surgical Pathology|April 15, 2015
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical ExpressionBeth Dudley, Randall E Brand, Darcy Thull, et al.
The American Journal of Surgical Pathology|May 8, 2013
A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissueAnne M Mills, Frances P Guo, Andrew P Copland, et al.
Histopathology|June 20, 2020
Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapySusan Shyu, Haroon Choudry, Lauren Hall, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant ImatinibJoshua B Brown, Reetesh K Pai, Melissa A Burgess, et al.
The American Journal of Surgical Pathology|July 21, 2016
MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional AdenomasLama Farchoukh, Shih-Fan Kuan, Beth Dudley, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 4, 2016
Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 DeficiencyMichelle Xia, Aatur D Singhi, Beth Dudley, et al.
The American Journal of Surgical Pathology|July 19, 2019
Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and AdenocarcinomaChangqing Ma, Patrick Henn, Caitlyn Miller, et al.
The Journal of Molecular Diagnostics : JMD|April 29, 2005
B-cell clonality determination using an immunoglobulin kappa light chain polymerase chain reaction methodReetesh K Pai, Artemis E Chakerian, John M Binder, et al.
Human Pathology|July 4, 2012
Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtypingMichael A DiMaio, Shirley Kwok, Kelli D Montgomery, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 5, 2017
A Polyclonal Antibody to NKX3.1 Identifies Fungal Organisms From the EsophagusMartina Pejchal, Reetesh K Pai, Nadia F Habib-Bein, et al.
The American Journal of Surgical Pathology|April 15, 2015
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical ExpressionBeth Dudley, Randall E Brand, Darcy Thull, et al.
The American Journal of Surgical Pathology|May 8, 2013
A comparison of CMV detection in gastrointestinal mucosal biopsies using immunohistochemistry and PCR performed on formalin-fixed, paraffin-embedded tissueAnne M Mills, Frances P Guo, Andrew P Copland, et al.
Histopathology|June 20, 2020
Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapySusan Shyu, Haroon Choudry, Lauren Hall, et al.
Pageof 14